|
|||||
|
|
Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma |
|
| Authors: | Yan-Yu Wang Xu Yang Yun-Chao Wang Jun-Yu Long Hui-Shan Sun Yi-Ran Li Zi-Yu Xun Nan Zhang Jing-Nan Xue Cong Ning Jun-Wei Zhang Cheng-Pei Zhu Long-Hao Zhang Xiao-Bo Yang Hai-Tao Zhao |
| Abstract: | |
| Keywords: | Lenvatinib Programmed death receptor-1 inhibitor Immunotherapy Hepatocellular carcinoma Transarterial chemoembolization Combination therapy |
| 点击此处可从《World journal of gastroenterology : WJG》浏览原始摘要信息 | |